184 related articles for article (PubMed ID: 19167889)
41. Employment status of patients with neuromuscular diseases in relation to personal factors, fatigue and health status: a secondary analysis.
Minis MA; Kalkman JS; Akkermans RP; Engels JA; Huijbregts PA; Bleijenberg G; Oostendorp RA; van Engelen BG
J Rehabil Med; 2010 Jan; 42(1):60-5. PubMed ID: 20111846
[TBL] [Abstract][Full Text] [Related]
42. The prevalence of hereditary neuromuscular disorders in Northern Norway.
Müller KI; Ghelue MV; Lund I; Jonsrud C; Arntzen KA
Brain Behav; 2021 Jan; 11(1):e01948. PubMed ID: 33185984
[TBL] [Abstract][Full Text] [Related]
43. WITHDRAWN: Rehabilitation interventions for foot drop in neuromuscular disease.
Sackley CM; Disler PB; Turner-Stokes L; Wade DT; Brittle N; Hoppitt T
Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD003908. PubMed ID: 25927103
[TBL] [Abstract][Full Text] [Related]
44. [Indices of the state of the pituitary-adrenal system in hereditary myopathies].
Temin PA; Gerasimova OI; Savost'ianova NA; Medvedev MI; Faustov VS
Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(3):342-6. PubMed ID: 6266180
[No Abstract] [Full Text] [Related]
45. Upper vs lower extremity functional loss in neuromuscular disease.
Lord JP; Portwood MM; Fowler WM; Lieberman JS; Carson R
Arch Phys Med Rehabil; 1987 Jan; 68(1):8-9. PubMed ID: 3800628
[TBL] [Abstract][Full Text] [Related]
46. Mitochondrial respiratory chain dysfunction in various neuromuscular diseases.
Jongpiputvanich S; Sueblinvong T; Norapucsunton T
J Clin Neurosci; 2005 May; 12(4):426-8. PubMed ID: 15925774
[TBL] [Abstract][Full Text] [Related]
47. Development of a tool to guide referral of patients with neuromuscular disorders to allied health services. Part one.
Pieterse AJ; Cup EH; Knuijt S; Hendricks HT; van Engelen BG; van der Wilt GJ; Oostendorp RA
Disabil Rehabil; 2008; 30(11):855-62. PubMed ID: 17852320
[TBL] [Abstract][Full Text] [Related]
48. Is the disability of arm, shoulder, and hand questionnaire (DASH) also valid and responsive in patients with neck complaints.
Huisstede BM; Feleus A; Bierma-Zeinstra SM; Verhaar JA; Koes BW
Spine (Phila Pa 1976); 2009 Feb; 34(4):E130-8. PubMed ID: 19182703
[TBL] [Abstract][Full Text] [Related]
49. [Neuromuscular disease: health care accessibility in the Nord-Pas-de- Calais region].
Donzé C; Delattre S; Viet G; Thevenon A
Rev Neurol (Paris); 1999 Dec; 155(12):1063-70. PubMed ID: 10637926
[TBL] [Abstract][Full Text] [Related]
50. Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: a multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trial.
Orlikowski D; Chevret S; Quera-Salva MA; Laforêt P; Lofaso F; Verschueren A; Pouget J; Eymard B; Annane D
Clin Ther; 2009 Aug; 31(8):1765-73. PubMed ID: 19808135
[TBL] [Abstract][Full Text] [Related]
51. Responsiveness of the Gait Domain of the Functional Evaluation Scale for Children with Duchenne Muscular Dystrophy.
de Carvalho EV; Caromano FA; Goya PSA; Hukuda ME; Voos MC
Phys Occup Ther Pediatr; 2019; 39(1):107-118. PubMed ID: 29851524
[TBL] [Abstract][Full Text] [Related]
52. Comparative responsiveness of the Michigan Hand Outcomes Questionnaire and the Carpal Tunnel Questionnaire after carpal tunnel release.
Chatterjee JS; Price PE
J Hand Surg Am; 2009 Feb; 34(2):273-80. PubMed ID: 19181227
[TBL] [Abstract][Full Text] [Related]
53. Duchenne muscular dystrophy: issues in expanding newborn screening.
Kemper AR; Wake MA
Curr Opin Pediatr; 2007 Dec; 19(6):700-4. PubMed ID: 18025940
[TBL] [Abstract][Full Text] [Related]
54. Validation of the Clinical COPD Questionnaire as a psychophysical outcome measure in adult laryngotracheal stenosis.
Nouraei SA; Randhawa PS; Koury EF; Abdelrahim A; Butler CR; Venkataraman A; Howard DJ; Sandhu GS
Clin Otolaryngol; 2009 Aug; 34(4):343-8. PubMed ID: 19673982
[TBL] [Abstract][Full Text] [Related]
55. Patient-preference disability assessment for disabling chronic low back pain: a cross-sectional survey.
Sanchez K; Papelard A; Nguyen C; Jousse M; Rannou F; Revel M; Poiraudeau S
Spine (Phila Pa 1976); 2009 May; 34(10):1052-9. PubMed ID: 19363459
[TBL] [Abstract][Full Text] [Related]
56. [Various features of muscle tissue metabolism in various muscular and neuromuscular diseases of a hereditary nature (clinico-histochemical study)].
Anosov NN; Saĭkova LA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(3):22-5. PubMed ID: 6952668
[TBL] [Abstract][Full Text] [Related]
57. Weakness and fatigue in diverse neuromuscular diseases.
Montes J; Blumenschine M; Dunaway S; Alter AS; Engelstad K; Rao AK; Chiriboga CA; Sproule DM; De Vivo DC
J Child Neurol; 2013 Oct; 28(10):1277-83. PubMed ID: 23847297
[TBL] [Abstract][Full Text] [Related]
58. Measurement in Duchenne muscular dystrophy: considerations in the development of a neuromuscular assessment tool.
Scott E; Mawson SJ
Dev Med Child Neurol; 2006 Jun; 48(6):540-4. PubMed ID: 16700951
[TBL] [Abstract][Full Text] [Related]
59. Adherence to american academy of pediatrics recommendations for cardiac care among female carriers of duchenne and becker muscular dystrophy.
Bobo JK; Kenneson A; Kolor K; Brown MA
Pediatrics; 2009 Mar; 123(3):e471-5. PubMed ID: 19254982
[TBL] [Abstract][Full Text] [Related]
60. Diagnostic accuracy of electrodiagnostic testing in the evaluation of weakness.
Nardin RA; Rutkove SB; Raynor EM
Muscle Nerve; 2002 Aug; 26(2):201-5. PubMed ID: 12210383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
